Skip to main content
. 2023 Apr 3;4(3):100190. doi: 10.1016/j.xhgg.2023.100190

Figure 2.

Figure 2

CancerSig prediction performance across cancers

(A) Evaluating the prediction performance of CancerSig using receiver operating characteristic (ROC) across 15 cancers. CancerSig obtained a mean area under the curve (AUC) of 0.80 across all cancers.

(B) Ranking of the relative miRNAs within the signature using MED analysis.